(Q35169109)

6 August 2017

1 reference

title

Impact and mechanism for oxidized and glycated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells (English)

1 reference

6 August 2017

0 references

Garry X Shen

1

1 reference

PubMed ID

12841345

6 August 2017

language of work or name

1 reference

1 April 2003

1 reference

Molecular and Cellular Biochemistry

6 August 2017

1 reference

6 August 2017

246

1 reference

6 August 2017

1-2

1 reference

6 August 2017

69-74

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1023455912456

6 August 2017

0 references

cites work

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

1 reference

12 December 2020

Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells

1 reference

12 December 2020

Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon

1 reference

12 December 2020

Immunohistochemical localization of plasminogen activator inhibitor-1 in human coronary atherosclerotic lesions involved in acute myocardial infarction

1 reference

12 December 2020

Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences

1 reference

12 December 2020

Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes

1 reference

12 December 2020

Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells

1 reference

12 December 2020

Plasminogen activation in diabetes mellitus. Kinetics of plasmin formation with tissue plasminogen activator and plasminogen from individual diabetic donors and with in vitro glucosylated plasminogen

1 reference

12 December 2020

The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus.

1 reference

12 December 2020

The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctu

1 reference

12 December 2020

Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells

1 reference

12 December 2020

Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells

1 reference

12 December 2020

Cell-associated plasminogen activation: regulation and physiological functions

1 reference

12 December 2020

Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements

1 reference

12 December 2020

Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins

1 reference

12 December 2020

Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia

1 reference

12 December 2020

Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells

1 reference

12 December 2020

Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina

1 reference

12 December 2020

Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis

1 reference

12 December 2020

Protein kinase C-beta mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells

1 reference

12 December 2020

Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).

1 reference

12 December 2020

Comparison of the effects of O2*-/HO* free radical- and copper ions-oxidized LDL or lipoprotein(a) on the endothelial cell releases of tissue plasminogen activator and plasminogen activator inhibitor-1.

1 reference

12 December 2020

Phosphatidylinositol turnover during stimulation of plasminogen activator inhibitor-1 secretion induced by oxidized low density lipoproteins in human endothelial cells

1 reference

12 December 2020

Glycation accelerates the oxidation of low density lipoprotein by copper ions

1 reference

12 December 2020

Effects of captopril on fibrinolytic function in healthy humans

1 reference

12 December 2020

Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.

1 reference

12 December 2020

Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein

1 reference

12 December 2020

Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.

1 reference

12 December 2020

Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells

1 reference

12 December 2020

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

1 reference

12 December 2020

The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family

1 reference

12 December 2020

Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells.

1 reference

12 December 2020

Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study

1 reference

12 December 2020

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

1 reference

12 December 2020

Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells

1 reference

12 December 2020

Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response

1 reference

12 December 2020

The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery Disease

1 reference

12 December 2020

Atherosclerosis and thrombosis: lessons from animal models.

1 reference

12 December 2020

Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells

1 reference

12 December 2020

Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control

1 reference

12 December 2020

HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells

1 reference

12 December 2020

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

1 reference

12 December 2020

Activity of tissue plasminogen activator and plasminogen activator inhibitor in noninsulin-dependent diabetes mellitus

1 reference

12 December 2020

Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia

1 reference

12 December 2020

Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial

1 reference

12 December 2020

Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women

1 reference

12 December 2020

Oxidative modification of Lp(a) causes changes in the structure and biological properties of apo(a).

1 reference

12 December 2020

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.

1 reference

12 December 2020

Pre-enrichment of modified low density lipoproteins with alpha-tocopherol mitigates adverse effects on cultured retinal capillary cells

1 reference

12 December 2020

Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure

1 reference

12 December 2020

Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide

1 reference

12 December 2020

Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells

1 reference

12 December 2020

Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells

1 reference

12 December 2020

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

12 December 2020

Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.

1 reference

12 December 2020

Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta

1 reference

12 December 2020

Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype

1 reference

12 December 2020

Coronary artery disease: pathogenesis and acute coronary syndromes

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1023455912456

1 reference

PubMed ID

12841345

Dimensions Publication ID

6 August 2017

0 references

1 reference

PubMed ID

12841345